| Literature DB >> 26977284 |
Hye-Sun Yu1, Jung-Ju Kim2, Hae-Won Kim3, Mark P Lewis4, Ivan Wall5.
Abstract
Mechanical loading is recognized to play an important role in regulating the behaviors of cells in bone and surrounding tissues in vivo. Many in vitro studies have been conducted to determine the effects of mechanical loading on individual cell types of the tissues. In this review, we focus specifically on the use of the Flexercell system as a tool for studying cellular responses to mechanical stretch. We assess the literature describing the impact of mechanical stretch on different cell types from bone, muscle, tendon, ligament, and cartilage, describing individual cell phenotype responses. In addition, we review evidence regarding the mechanotransduction pathways that are activated to potentiate these phenotype responses in different cell populations.Entities:
Keywords: Flexercell; bone; cartilage; ligament; mechanical strain; muscle; tendon
Year: 2016 PMID: 26977284 PMCID: PMC4765821 DOI: 10.1177/2041731415618342
Source DB: PubMed Journal: J Tissue Eng ISSN: 2041-7314 Impact factor: 7.813
Figure 1.Experimental setup of the Flexercell system for applying strain to cell populations. (a) Schematic representation of the computer-controlled Flexercell system that applies strain to cell monolayers in custom-made six-well plates. (b) Cross-sectional diagram of one well of a six-well Flexercell plate at rest (top) and upon application of the vacuum (bottom). (c) Strain can be applied in a variety of ways including uniaxial and equiaxial.
Summary of Flexercell studies and key findings using osteoblastic cells.
| Cell type | Stage of differentiation | Stretch device and regime | Key findings | Reference |
|---|---|---|---|---|
| Murine osteocytic (MLO-Y4) | Osteocytes | Flexercell 4000, 5% elongation, 10 min, 0.05–1 Hz | Estrogen receptor involved in strain-mediated pro-survival signaling via ERK | Aguirre et al.
|
| Human osteoblasts | 24-h culture in differentiation medium (early differentiation) | Flexercell,
| High strain increased proliferation, migration, VEGF and bFGF production | Bhatt et al.
|
| Low strain increased OCN and OPN | ||||
| Rat osteoblast (ROS 17/2.8) and mouse osteoblast (MC3T3-E1) | Early osteoblasts | Flexercell 3000, 1% elongation, 10 min, 0.25 Hz | Strain-induced rapid phosphorylation of ERK2 and FAK and activation of Ras/Raf/MEK pathway | Boutahar et al.
|
| Human osteosarcoma (TE-85) | Osteosarcoma | Flexercell,
| Strain-induced reorganizated distribution of integrins and increased β1 but not αν mRNA levels | Carvalho et al.
|
| Human osteosarcoma (SaOS-2) | Osteosarcoma | Flexercell,
| Increased expression of TGFβ1, IGF1, bFGF, IL6, but no change in IL1 | Cillo et al.
|
| Mouse osteoblast (CIMC-4) | Pre-osteoblast | Flexercell,
| Strain caused a reduction in RANKL, but upregulated OSX and RUNX2 via ERK1/2 | Fan et al.
|
| Rat osteoblast (ROS17/2.8) and human osteoblasts | Single cells; 24-h post-plating | Flexercell 3000, 1% elongation, 1.5–150 min, 0.05–5 Hz | Expression of soluble VEGF isoforms (121, 165) under low frequency | Faure et al.
|
| Expression of matrix-bound VEGF isoforms (206, 189, 165, 145) under high frequency | ||||
| Rat osteoblast (ROS17/2.8) | Mature osteoblasts (3 weeks in differentiation medium) | Flexercell 3000, 1% elongation, 10 min, 0.05 Hz | Stretch-induced activation of Egr-1 and nuclear translocation of NF-κB | Granet et al.
|
| Rat osteoblast (ROS 17/2.8) and mouse osteoblast (MC3T3-E1) | Early osteoblast | Flexercell 3000, 1% elongation, 15 cycles/min (2-s deformation period followed by a 2-s neutral position) | Induced phosphorylation of FAK, PYK2, paxillin and HIC5 | Guignandon et al.
|
| Murine calvarial osteoblasts | Early osteoblast (7–10 days post-plating) | Flexercell 4000, 2.5%–3% elongation, 3–24 h, 0.3 Hz | Stretch resulted in the activation of canonical Wnt signaling | Hens et al.
|
| Human fetal osteoblast (SV-HFO) | Differentiation medium | Bioflex loading stations, 0.4%, 5–60 min or 7–21 days, 0.05 Hz | Stretch-induced phosphorylation of ERK1/2 pathways dependent on differentiation stage | Jansen et al.
|
| Mouse osteoblast (MC3T3-E1) | 24 h in differentiation medium | Flexercell 4000, 0.25%–2.5%, 1 Hz, 15 min/day for 7 days | Overall increased RANKL due to increased membrane-bound RANKL but decreased soluble RANKL | Kim et al.
|
| Rat osteoblast and mouse osteoblast (MC3T3-E1) | Osteoblasts | Flexercell,
| Stretch increased DNA synthesis | Knoll et al.
|
| ALP decreased in response to strain and combined strain/TGFβ treatment | ||||
| Human osteoblast (HOB) | Osteoblasts | Flexercell 4000, 2.5% elongation, 0.1 Hz, intermittent strain 1 h, strain 3 h, and rest for 48 h | Increased DNA synthesis and IL6 production | Liegibel et al.
|
| No effect on ALP, COL I or OPG production | ||||
| Human osteosarcoma (SaOS-2) | 7 days post-plating | Flexercell,
| Low strain led to increased COL I and COL III expression | Liu et al.
|
| High strain led to decreased COL III expression | ||||
| Mouse osteoblast (MC3T3-E1) | Osteoblasts | Flexercell 2000, 7%–24% elongation, 3 cycles/min, 1–24 h | Increased expression of VEGF and M-CSF | Motokawa et al.
|
| Mouse osteoblast (MC3T3-E1) | Osteoblasts | Flexercell 4000, 0%–9% elongation, 3–24 h, 0.3 Hz | Stretch promoted COX2 but not COX1 expression | Narutomi et al.
|
| Murine osteocytic (MLO-Y4) | Osteocytes | Flexercell 4000, 2%–5%, 1–20 min | Activation of ERK via integrin/cytoskeleton/Src-mediated signaling | Plotkin et al.
|
| Mouse osteoblast (MC3T3-E1) | Osteoblasts | Flexercell 3000, 3400 microstrain, 2 Hz, 5 h | Increased Wnt/B-catenin target genes (Wnt10B, SFRP1, cyclin D1, FZD2, WISP2, and connexin 43) | Robinson et al.
|
| Mouse osteoblast (MC3T3-E1) | Osteoblasts | Flexercell 3000, 6%–18% elongation, 24 h, 0.1 Hz | Increased OPG synthesis and decreased RANKL expression | Tang et al.
|
| Human osteosarcoma (MG63) | Osteoblasts | Flexercell 3000, 10% elongation, 14 h, 0.5 Hz | Strain inhibited the promoter activation by vitamin D | Toyoshita et al.
|
| Rat osteoblast | Differentiation medium | Flexercell,
| Nodule formation was enhanced, depending on the timing of initiation and magnitude of the deformation regimen | Visconti et al.
|
| SV40 human osteoblasts | Differentiation medium | Flexercell 4000, 0.8%–3.2% elongation, 48 h, 1 Hz | High-magnitude strain led to increased expression of OC, COL I and Cbfa1/Runx2 | Zhu et al.
|
| Low-magnitude strain led to increased ALP activity |
ERK: extracellular-regulated protein kinase; VEGF: vascular endothelial growth factor; bFGF: basic fibroblast growth factor; OCN: osteocalcin; OPN: osteopontin; FAK: focal adhesion kinase; NF-κB: nuclear factor-κB; TGFβ1: transforming growth factor β1; COL: collagen; IGF1: insulin-like growth factor 1; IL: interleukin; PYK2: proline-rich tyrosine kinase 2; COX: cyclooxygenase; M-CSF: macrophage-colony stimulating factor; ALP: alkaline phosphatase; OPG: osteoprotegerin; MEK: mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase (ERK) kinase; RANKL: receptor activator of NF-kB ligand; OSX: osterix; RUNX2: Runt-related transcription factor 2; Egr-1: Early growth response protein 1; HIC5: hydrogen peroxide-inducible clone-5.
Flexercell model not specified.
Figure 2.A series of processes from MPCs to differentiated myotubes.
Summary of Flexercell studies and key findings using muscle cells.
| Cell type | Stage of differentiation | Stretch device and regime | Key findings | Reference |
|---|---|---|---|---|
|
| ||||
| Murine myoblast (C2C12) | Confluent/early fusion | Flexercell 4000, cyclical stretch at 3% at 0.05 Hz for 24–72 h | Increased MyoD, MyoG, Mef2, MHC | Bruce et al.
|
| Stretch abrogated the reductions in the expression of the above by TNFα treatment | ||||
| Murine myoblast (C2C12) | Single cells; 24-h post-plating | Flexercell,
| Increased proliferation | Iwanuma et al.
|
| Increased IGF1 and caspase mRNA expression in the initial 24 h of stretch | ||||
| Murine myoblast (C2C12) | MDC | Flexercell 4000, 15% strain for 10 min | Overexpression of REDD2 inhibits response of mTOR to mechanical stimulation | Miyazaki and Esser
|
| Rat MDCs | >95% desmin-positive single MDCs | Flexercell 2000, 12–36 h post-plating at 25% strain for 12–36 h with 12-s intervals | Increase in BrdU + cells after 12-h stretch | Tatsumi et al.
|
| Increase in HGF in CM at 12 h. Anti-HGF antibody prevents increase in BrdU + cells. Stretch releases pre-existing HGF from ECM | ||||
| Rat MDCs | >95% Desmin positive single MDCs | Flexercell 2000, 12–36 h post-plating at 25% strain for 24 h with 12 s intervals | Increase in LH limb BrdU + cells compared to BK and UH cultures following stretch. Increase in HGF in CM of LH cultures stretch compared to BK and UH | Tatsumi et al.
|
| Rat MDCs | >95% desmin-positive single MDCs | Flexercell 2000, 12–36 h post-plating at 25% strain for 24 h with 12-s intervals | Increase in BrdU + cells at an optimal pH (7.2) | Tatsumi et al.
|
| Increase in BrdU + cells in a HGF- and NO-dependent mechanism | ||||
| Rat MDCs | Single MDCs | Flexercell 2000, 12–36 h post-plating at 25% strain for 24 h with 12-s intervals | Stretch activation of BrdU + cells is NO dependent | Tatsumi et al.
|
| Rat MDCs | Single MDCs | Flexercell 2000, 25% strain, 12-s intervals for 2 h | Stretch induced an increase in the active form of MMP2 in a NO-dependent mechanism | Yamada et al.
|
|
| ||||
| Murine myoblast (C2C12) and murine MDCs | Single cells induced to differentiate; 24-h post-seeding (C2C12) or immediately post-seeding (MDCs) | Flexercell 4000, 48 h uniaxial ramp stretch, followed by intermittent strain at 2%–6% strain for 4 days. Cyclic stretch at 1 Hz | 2D: reductions in MRF-4 and MYH-4 mRNA in both cell types. Increase in MYH-1 mRNA (C2C12 only) | Boonen et al.
|
| 3D: reductions in MRFs, MyoD, myogenin (both cell types) MRF-4 (C2C12) and MLP (MDCs). Increases in actin and α-actinin mRNA at day 4 (C2C12), reduction in MYH mRNAs (both cell types) | ||||
| Murine myoblast (C2C12) | Single cells induced to differentiate | Flexercell 4000, 17% cyclical stretch, 1 Hz for 1 h every 24 h for 5 days | Stretch increased proliferation and inhibited differentiation | Kumar et al.
|
| Murine myoblast (C2C12) | Single cells induced to differentiate | Flexercell,
| Stretch improved proliferation | Kurokawa et al.
|
| Stretch led to increased MHC-perinatal expression | ||||
| Fast stretch led to early expression, slow led to later expression | ||||
| Rat myoblasts (L6) | Single cells induced to differentiate | Flexercell 4000, 20% cyclical strain at 0.5 Hz for up to 24 h | Stretch caused caspase-induced apoptosis during differentiation | Liu et al.
|
| Murine MDCs isolated from WT and | 24 h in differentiation medium (early differentiation) | Flexercell,
| Increase in real time measurement of NO production during
stretch (WT). No observed increase in NO in | Wozniak and Anderson
|
| P1–P2 rat MDCs | Confluent single cells | Flexercell,
| Stretch induced an increase in Na+ pump activity, increased expression of α-2 subunit of Na+-K+-ATPase in the membrane fractions. Mediated through PI3-K | Yuan et al.
|
| Murine myoblast (C2C12) | Single cells induced to differentiate | Flexercell,
| Increase in actin fiber formation, myotube maturation (increase in α-actinin and striations) and myotube diameter with stretch. β1D and FAK proposed mediated mechanism | Zhang et al.
|
|
| ||||
| Rat myoblasts (L6) | Myotubes (7–9 days in culture) | Flexercell 4000, 1 Hz at 15% strain at 2, 15, 30, 60, 90, 120, and 150 min | Sarcoplasmic protein synthesis was unaltered; however, myofibrillar protein synthesis was decreased. Paradoxically, anabolic signaling (phosphorylation of key proteins) was enhanced | Atherton et al.
|
| Human MDCs | Stretched during differentiation or 10-min stretch after 7-day differentiation | Flexercell 2000, cyclical strain during differentiation | Stretching during differentiation increase CK activity | Clarke and Feeback
|
| 10%–20% cyclical strain | Acute stretching caused membrane wounding and FGF release | |||
| Mouse diaphragm MDCs | Myotubes (5 days in DM) | Flexercell,
| No effect of stretch on proinflammatory marker gene expression | Demoule et al.
|
| Rat myoblasts (L6) | Myotubes (7 days in DM) | Flexercell 3000, 10% stretch, 4 h, 1.5 Hz | Mechanical stretch plus oxidative stress (induced by SIN-1) causes sarcolemmal injury to a greater extent than either component alone | Ebihara et al.
|
| Rat myoblasts (L6) | Early myotubes | Flexercell 3000, 96 h of cyclical strain (18% stretch, 0.16 Hz) +/− heat stress | Total protein, HSP72 and 90 protein concentrations were increased by stretch and heat in a cumulative manner | Goto et al.
|
| Murine myoblast (C2C12) | Myotubes (5–6 days post-induction of differentiation) | Flexercell 3000, 15% stretch, 1 Hz, 10 min, cyclical | Increased phosphorylation of p70s6k following multiaxial versus uniaxial | Hornberger et al.
|
| Murine myoblast (C2C12) | Myotubes (5–6 days post-induction of differentiation) | Flexercell 3000, 15% stretch, 1 Hz, 10 min, cyclical | Stretch caused phosphorylation of p70s6k | Hornberger
|
| Addition of locally acting growth factors to myotubes did not have the same effect | ||||
| Rat MDCs | Early myotubes (8–10 days post initial plating) | Flexercell 2000, up to 24 h cyclical stretch, 0.25 Hz, 24% strain | 24 h stretching increased Ach esterase activity | Hubatsch and Jasmin
|
| Rat myoblasts (L6) | Myotubes; 7–8 days post-plating and in DM | Flexercell 100C, 25% cyclical stretch at 0.5 Hz for up to 48 h | Stretch caused increased glucose uptake in myotubes, not myoblasts independent of GLUT1 and 4 receptor content | Mitsumoto and Klip
|
| Murine myoblast (C2C12) | Early myotubes (24-h DM) | Flexercell,
| Increase LDH into CM. Neutrophil cytotoxicity of muscle cell membrane mediated by MPO | Nguyen et al.
|
| Human MDCs | Myotubes (5 days in DM) | Flexercell 4000, 0.25 Hz at 1.5, 4.9, 9.5, and 15% strains, for 30 min, 2 s on, 2 s off | Increased injury index and neutrophil chemotaxis with increased strain. Increases in IL8 and MCP-1 in conditioned media | Peterson and Pizza
|
| Rat myoblasts (L6) and rat MDC-sarcoglycan (SG) deficient | Myotubes | Flexercell,
| Increase in creatine phosphokinase in CM following stretch. Stretch-induced damage in SG-deficient cells caused by alteration in Ca2+ dynamics | Sampaolesi et al.
|
| Human MDCs | Myotubes (5 days in DM) | Flexercell 4000, 0.25 Hz for 2 h at 5%, 10%, 20%, or 30% strain | Lower myotube injury index at lower strains compared to higher strains and scrape injury (based on LDH in CM). Evidence for membrane rupture and an increase in lanthanum-rimmed membrane blebs (sign of injury) at 30% strain. Increased chemotaxis index of neutrophils using CM at higher strains | Tsivitse et al.
|
Mef2: mouse embryonic fibroblasts 2; MHC: myosin heavy chain; TNFα: tumor necrosis factor α; IGF1: insulin-like growth factor 1; MDC: myeloid-derived suppressor cell; mTOR: mammalian target of rapamycin; BrdU: bromodeoxyuridine; HGF: hepatocyte growth factor; CM: conditioned media; ECM: extracellular matrix; NO: nitric oxide; MMP2: matrix metallopeptidase 2; 2D: two-dimensional; MRF: myogenic regulatory factor; 3D: three-dimensional; PI3-K: phosphoinositide 3-kinase; FAK: focal adhesion kinase; CK: creatine kinase; FGF: fibroblast growth factor; GLUT1 and 4: glucose transporters 1 and 4; LDH: lactate dehydrogenase; IL8: interleukin 8; MCP-1: monocyte chemoattractant protein-1; MyoG: myogenin; REDD2: regulated in development and DNA damage responses 2; MYH: myosin, heavy chain; MLP: muscle LIM protein; WT: normal C57BL/6 wild-type; SIN-1: 3-morpholinosydnonimine-N-ethylcarbamide; HSP72: heat shock proteins; LH: lower hind; BK: back; UH: upper hind; Ach: acetylcholinesterase; MPO: myeloperoxidase.
Flexercell model not specified.
Summary of Flexercell studies and key findings using ligament cells.
| Cell type | Stage of differentiation | Stretch device and regime | Key findings | Reference |
|---|---|---|---|---|
| Human PDL | Confluent single cells | Flexercell,
| Suppressed IL1β-induced COX2 expression TENS-H upregulated COX2 expression and PGE2 synthesis | Agarwal et al.
|
| Human PDL | Single cells | Flexercell,
| Increased expression of MMP1, MMP2, TIMP1, TIMP2, α6 and β1 | Bolcato-Bellemin et al.
|
| Human PDL | Single cells | Flexercell,
| Decreased ALP activity | Chiba and Mitani
|
| Canine ACL and MCL | Single cells | Flexercell 2000, 5% (0.05 strain) strain at 6 cycles/min for 2 or 22 h daily for 3 days | Increased α5 and β1 expression | Hannafin et al.
|
| Increased β3 expression when cells grown on laminin | ||||
| Canine ACL | Confluent single cells | Flexercell 2000, 5%–15% strain at 6 cycles/min for 2 h followed by 22-h rest for 5 consecutive days | Increased α5 and β1 expression | Henshaw et al.
|
| Human PDL | Confluent single cells | Flexercell 2000, 9% strain at 6 cycles/min consisting of 5 s strain, 5 s for 6 days | Increased UNCL expression | Kim et al.
|
| Human PDL | Single cells | Flexercell,
| Increased TGFβ1 levels | Kimoto et al.
|
| Decreased M-CSF expression | ||||
| Canine ACL and MCL | Confluent single cells | Flexercell,
| ACL: Increased COL I | Hsieh et al.
|
| MCL: Increased COL III | ||||
| Rat MCL | Confluent single cells | Flexercell,
| Increased sensitivity to load and ability to propagate a calcium wave | Jones et al.
|
| Human PDL | Osteoblast-like characteristics | Flexercell,
| Low-magnitude strain inhibited IL1β-induced synthesis of IL11, IL6, and IL8 and induced IL10 synthesis | Long et al.
|
| Human PDL | Confluent single cells | Flexercell 2000, 9%–18% strain for 6 cycles/min consisting of 5 s strain, 5 s rest, 1–5 days | Increased ALP and OCN expression | Matsuda et al.
|
| EGF/EGF-R system acts as a negative regulator of differentiation | ||||
| Human LFC | Confluent | Flexercell 2000, 10%–20% strain, 0.16 Hz, 24–48 h | Increased COL I, III, and V via TGFβ1 | Nakatani et al.
|
| Bovine PDL | Confluent | Bioflex loading stations, 0.2%–18% stretch for 6 cycles/min consisting of 5 s strain, 5 s rest, 48 h | High-magnitude strain increased COL I and decorin expression but decreased ALP | Ozaki et al.
|
| Human PDL | Confluent | Flexercell,
| Increased activity of plasminogen activator | Ozawa et al.
|
| Rat PDL (6-week young rats and 60-week old rats) | Confluent | Flexercell,
| Increased PGE2 and IL1β production by old versus young in response to strain | Shimizu et al.
|
| Human PDL | Confluent | Flexercell,
| Rapid, transient increase in C-FOS expression | Yamaguchi et al.
|
| No change in expression of osteogenic genes | ||||
| Human PDL | Confluent | Flexercell 4000, 12% for 6 s every 90 s, 6, 12, and 24 h | Increased expression of BMP2, BMP6, ALP, SOX9, MSX1, and VEGFA | Wescott et al.
|
| Decreased expression of BMP4 and EGF | ||||
| Human PDL | Confluent | Flexercell,
| Increased VEGF expression and secretion | Yoshino et al.
|
PDL: periodontal ligament; IL: interleukin; COX2: cyclooxygenase 2; PGE2: prostaglandin E2; MMP: matrix metallopeptidase; TIMP: tissue inhibitors of metalloproteinases; ALP: alkaline phosphatase; ACL: anterior cruciate ligament; MCL: medial collateral ligament; UNCL: ulnar collateral ligament; TGFβ1: transforming growth factor β1; M-CSF: macrophage-colony stimulating factor; OCN: osteocalcin; EGF: epidermal growth factor; EGF-R: epidermal growth factor receptor; BMP: bone morphogenetic protein; VEGFA: vascular endothelial growth factor A; TENS-L: tensile strain of low magnitude; TENS-H: tensile strain of high magnitude; LFC: Ligamenturn flavum cells; C-FOS: FBJ murine osteosarcoma viral oncogene; SOX9: SRY (sex determining region Y)-box 9; MSX1: Msh homeobox 1.
Flexercell model not specified.
Summary of Flexercell studies and key findings using tendon cells.
| Cell type | Stage of differentiation | Stretch device and regime | Key findings | Reference |
|---|---|---|---|---|
| Rabbit Achilles tendon | Tenocytes | Flexercell 3000, 5% elongation, 0.33 Hz for 6 h with 18 h of rest | Synergistic effect of strain and IL1β to upregulate the production of stromelysin pro-enzyme | Archambault et al.
|
| Strain alone induced no effect | ||||
| Canine patellar tendon | Tenocytes | Flexercell 3000, 1%–9% strain, 0.5–3.0 Hz, 15–120 min | Transient JNK activation peaking at 30 min and returning to basal levels by 2 h | Arnoczky et al.
|
| Avian flexor tendon | Epitenon and tendon internal fibroblasts | Flexercell 2000, 5% elongation, 1 Hz for 8 h | Strain stimulates proliferation in the presence of PDGF-BB and IGF1 and promotes phosphorylation in multiple proteins | Banes et al.
|
| Avian flexor tendon | Tenocytes | Flexercell,
| Induced expression of numerous novel genes | Banes et al.
|
| Porcine posterior tibial tendon | Tenocytes | Flexercell,
| Increased COL I and decorin gene expression | Chen et al.
|
| Human tenosynovial fibroblasts | Tenosynovial fibroblasts | Flexercell,
| Increased expression of PGE2 and VEGF | Hirata et al.
|
| Human tendon | Tendon internal fibroblasts forming bioartificial tendons | Flexercell 4000, 30% strain for 10 s | IL1β low dose upregulated elastin expression and high dose suppressed COL I expression to increase elasticity and prevent rupture due to strain | Qi et al.
|
| Human tendon | Tendon internal fibroblasts forming bioartificial tendons | Flexercell 4000, 3.5% elongation, 1 Hz, for 1 h/day | IL1β reduced Young’s modulus in bioartificial tendons, increasing their tolerance to mechanical strain | Qi et al.
|
| Avian flexor tendons | Tenocytes | Flexercell,
| Increased junctional components n-cadherin and vinculin, but no change in actin levels | Ralphs et al.
|
| Human flexor tendons | Tenocytes | Flexercell,
| Stimulation of ecto-ATP activity | Tsuzaki et al.
|
| Human flexor tendons | Tenocytes | Flexercell,
| Induced IL1β, COX2 and MMP3, but not MMP1 | Tsuzaki et al.
|
| ATP modulated stretch-induced gene expression | ||||
| Human flexor tendons | Tendon internal fibroblasts | Flexercell 3000, 3%–5% strain at 1 Hz for 1–6 h | Connexin 43 colocalization with actin increased with strain | Wall et al.
|
IL1β: interleukin 1β; PDGF-BB: platelet-derived growth factor-BB; IGF1: insulin-like growth factor 1; PGE2: prostaglandin E2; VEGF: vascular endothelial growth factor; COX2: cyclooxygenase 2; MMP: matrix metallopeptidase; JNK: c-Jun N-terminal kinase.
Flexercell model not specified.
Summary of Flexercell studies and key findings using chondrocytes.
| Cell type | Stage of differentiation | Stretch device and regime | Key findings | Reference |
|---|---|---|---|---|
| Rabbit articular cartilage | Chondrocytes | Flexercell,
| Low stretch: inhibitor of IL1β-dependent NF-κB nuclear translocation | Agarwal et al.
|
| High stretch: involvement of NF-κB nuclear translocation and synthesis | ||||
| Rat articular cartilage | Chondrocytes | Flexercell 2000, 7% elongation, 0.5 Hz, cyclic stretch (1 s on, 1 s off) | Upregulated expression of MMP13 and cathepsin B | Doi et al.
|
| No effect on the expression of aggrecan and COL II | ||||
| Rat articular cartilage | Chondrocytes | Flexercell 4000, 3%, 0.25 Hz, in the presence or absence of IL1β | Inhibitor of IL1β-dependent NF-κB nuclear translocation and cytoplasmic degradation of IκBβ and IκBα | Dossumbekova et al.
|
| Human chondrosarcoma (HCS-2/8) | Chondrocytes | Flexercell,
| High magnitude and frequency gene expression of IL1 and MMP9 | Fujisawa et al.
|
| Mid frequency: 1 cycle/2 min | Continuous stress induces the production of IL1 and MMP9 | |||
| Low frequency: 1 cycle/4 min | ||||
| Bovine articular cartilage | Chondrocytes | Flexercell,
| Increased proteoglycan synthesis at low frequency and magnitude | Fukuda et al.
|
| Lower stress at 10 cycle/h, 5% | Decreased proteoglycan synthesis at high frequency and magnitude | |||
| Rabbit articular cartilage | Chondrocytes | Flexercell,
| Anti-inflammatory effect by inhibiting iNOS and therefore NO in IL1β-activated chondrocytes | Gassner et al.
|
| Rabbit articular cartilage | Chondrocytes (retain their differentiated phenotype) | Flexercell,
| Reverses IL1β-induced suppression of proteoglycan synthesis | Gassner et al.
|
| Bovine articular cartilage and human chondrosarcoma (105KC) | Chondrocytes | Flexercell,
| Primary cells: increased COL II expression with no change in β1 integrin | Holmvall et al.
|
| 105KC: increased α5 expression with no change in β1, α2 or αν | ||||
| Porcine articular cartilage | Chondrocytes | Flexercell 4000, 10% strain, 0.5 Hz, 1–24 h | Increased NO, PGE2 and COX2 expression | Huang et al.
|
| Anabolic response: Increased COL II and aggrecan expression as an early response | ||||
| Catabolic response: Increased TGFβ and MMP1 expression at 24 h | ||||
| Human articular cartilage | Chondrocytes | Flexercell,
| Increased proliferation | Lahiji et al.
|
| Enhanced expression of COL II and aggrecan | ||||
| Enhanced integrin α2 but no change in α5 or β1 | ||||
| Rabbit articular cartilage | Chondrocytes (retaining their differentiated phenotype) | Flexercell,
| Abrogated TNFα-induced inhibition of proteoglycan synthesis | Long et al.
|
| Rat articular cartilage | Chondrocytes (retaining their differentiated phenotype) | Flexercell 4000, 3%, 0.25 Hz, 4–24 h | Blocking of IL1β-dependent pro-inflammatory gene expression (iNOS, COX2, MMP9 and MMP13) | Madhavan et al.
|
| Bovine articular cartilage | Chondrocytes | Flexercell 3000, 7%, the frequency (10 cycles/min, 3 s) | Enhanced NO synthesis that inhibited PG synthesis | Matsukawa et al.
|
| Rat articular cartilage | Chondrocytes | Flexercell,
| Protective effect of IL4 on matrix synthesis | Shimizu et al.
|
| Rat articular cartilage | Chondrocytes | Flexercell,
| Decreased proteoglycan synthesis and PKC activity | Tanaka et al.
|
| Bovine articular cartilage | Chondrocytes | Flexercell 3000, high (10 cycles/min), low (10 cycles/h) | Caused depolymerization of HA and induced ROS generation | Yamazaki et al.
|
| Rabbit fibrochondrocytes from TMJ | Chondrocytes (retain their differentiated phenotype) | Flexercell,
| Stretch suppresses IL1β-dependent induction of COX2 and PGE2 synthesis | Agarwal et al.
|
| Human chondrosarcoma (CS-OKB) | Confluent | Flexercell,
| Induces the expression of a heat shock protein termed stress-induced chondrocytic (SIC) 1 | Chano et al.
|
| Rat fibrochondrocytes from TMJ | Chondrocytes (retain their differentiated phenotype) | Bioflex loading stations, 20%, 0.05 Hz, 1–20 h | IL1β-induced expression of several MMPs inhibited | Deschner et al.
|
| Rat fibrochondrocytes from TMJ | Chondrocytes (retain their differentiated phenotype) | Flexercell 4000, 20%, 0.05 Hz, 1–24 h | Inhibits IL1β-induced expression of TNFα, TNFR2 and iNOS, but not TNFR1 | Deschner et al.
|
IL1β: interleukin 1β; NF-κB: nuclear factor-κB; MMP: matrix metallopeptidase; iNOS: inducible nitric oxide synthase; NO: nitric oxide; TNFα: tumor necrosis factor α; COX2: cyclooxygenase 2; PG: proteoglycan; PKC: protein kinase C; ROS: reactive oxygen species; TMJ: temporomandibular joint; PGE2: prostaglandin E2; TNFR: tumor necrosis factor receptor; IκB: nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor; HA: Hyaluronan.
Flexercell model not specified.